Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 August 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 207 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 63 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
E. Nortoft, Chubb, B., and Borglykke, A., Obesity and healthcare resource utilization: comparative results from the UK and the USA, Obes Sci Pract, vol. 4, pp. 41-45, 2018.
C. W. le Roux, Chubb, B., Nortoft, E., and Borglykke, A., Obesity and healthcare resource utilization: results from Clinical Practice Research Database (CPRD), Obes Sci Pract, vol. 4, pp. 409-416, 2018.
B. D. Bradbury, Wilk, J. B., and Kaye, J. A., Obesity and the risk of prostate cancer (United States), Cancer Causes Control, vol. 16, pp. 637-41, 2005.
N. Yurgin, Secnik, K., and Lage, M. J., Obesity and the use of insulin: a study of patients with type 2 diabetes in the UK, J Diabetes Complications, vol. 22, pp. 235-40, 2008.
C. W. Choi, Kim, G. H., Song, C. S., Wang, S. G., Lee, B. J., I, H., Kang, D. H., and Song, G. A., Is obesity associated with gastropharyngeal reflux disease?, World J Gastroenterol, vol. 14, pp. 265-71, 2008.
C. W. le Roux, Hartvig, N. V., Haase, C. L., Nordsborg, R. B., Olsen, A. H., and Satylganova, A., Obesity, cardiovascular risk and healthcare resource utilization in the UK, Eur J Prev Cardiol, p. 2047487320925639, 2020.
K. Bowman, Delgado, J., Henley, W. E., Masoli, J. A., Kos, K., Brayne, C., Thokala, P., Lafortune, L., Kuchel, G. A., Ble, A., and Melzer, D., Obesity in Older People With and Without Conditions Associated With Weight Loss: Follow-up of 955,000 Primary Care Patients, J Gerontol A Biol Sci Med Sci, vol. 72, pp. 203-209, 2017.
G. Thomas, Khunti, K., Curcin, V., Molokhia, M., Millett, C., Majeed, A., and Paul, S., Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease, Diabetes Obes Metab, vol. 16, pp. 317-25, 2014.
R. Das, Langerman, H., D'Oca, K., and Strongman, H., An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK, Value Health, vol. 17, p. A360, 2014.
G. Glover, Williams, R., and Oyinlola, J., An observational cohort study of numbers and causes of preventable general hospital admissions in people with and without intellectual disabilities in England, J Intellect Disabil Res, 2020.
J. D. Blakey, Gayle, A., Slater, M. G., Jones, G. H., and Baldwin, M., Observational cohort study to investigate the unmet need and time waiting for referral for specialist opinion in adult asthma in England (UNTWIST asthma), BMJ Open, vol. 9, p. e031740, 2019.
G. C. Hall, Morant, S. V., Carroll, D., Gabriel, Z. L., and McQuay, H. J., An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population, BMC Fam Pract, vol. 14, p. 28, 2013.
G. Glover, Williams, R., Tompkins, G., and Oyinlola, J., An observational study of the use of acute hospital care by people with intellectual disabilities in England, J Intellect Disabil Res, 2018.
G. Glover, Williams, R., Tompkins, G., and Oyinlola, J., An observational study of the use of acute hospital care by people with intellectual disabilities in England, J Intellect Disabil Res, vol. 63, pp. 85-99, 2019.
S. Hennessy, Bilker, W. B., Leonard, C. E., Chittams, J., Palumbo, C. M., Karlawish, J. H., Yang, Y. X., Lautenbach, E., Baine, W. B., and Metlay, J. P., Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures, J Clin Epidemiol, vol. 60, pp. 911-8, 2007.
C. van Durme, Spaetgens, B., Driessen, J., Nielen, J., Sastry, M., Boonen, A., and de Vries, F., Obstructive sleep apnea and the risk of gout: a population-based case-control study, Arthritis Res Ther, vol. 22, p. 92, 2020.
L. Watson, Kerstjens, H. A., Rabe, K. F., Kiri, V., Visick, G. T., and Postma, D. S., Obtaining optimal control in mild asthma: theory and practice, Fam Pract, vol. 22, pp. 305-10, 2005.
D. C. Hesdorffer, Ishihara, L., Webb, D. J., Mynepalli, L., Galwey, N. W., and Hauser, W. A., Occurrence and Recurrence of Attempted Suicide Among People With Epilepsy, JAMA Psychiatry, vol. 73, pp. 80-6, 2016.
L. A. Garcia Rodriguez, Mannino, S., and Wallander, M. A., Ocular safety of antiulcer drugs, Lancet, vol. 345, pp. 1059-60, 1995.
C. D. Poole, Halcox, J. P., Jenkins-Jones, S., Carr, E. S., Schifflers, M. G., Ray, K. K., and Currie, C. J., Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study, Clin Ther, vol. 35, pp. 40-51, 2013.
C. R. Meier and Jick, H., Omeprazole, H2 blockers, and polyarthralgia: case-control study, Bmj, vol. 315, p. 1283, 1997.
C. R. Meier and Jick, H., Omeprazole, other antiulcer drugs and newly diagnosed gout, Br J Clin Pharmacol, vol. 44, pp. 175-8, 1997.
S. J. Price, Stapley, S. A., Shephard, E., Barraclough, K., and Hamilton, W. T., Is omission of free text records a possible source of data loss and bias in Clinical Practice Research Datalink studies? A case-control study, BMJ Open, vol. 6, p. e011664, 2016.
R. Buhl, Heaney, L. G., Loefroth, E., Larbig, M., Kostikas, K., Conti, V., and Cao, H., One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings, Respir Med, vol. 162, p. 105859, 2019.
A. Ruigomez, Wallander, M. A., Johansson, S., and Rodriguez, L. A. Garcia, One-year follow-up of newly diagnosed irritable bowel syndrome patients, Aliment Pharmacol Ther, vol. 13, pp. 1097-102, 1999.
C. R. Chapman and Bradshaw, D. H., Only modest long-term opioid dose escalation occurs over time in chronic nonmalignant pain management, J Pain Palliat Care Pharmacother, vol. 27, pp. 370-7, 2013.
T. A. Hammad, Graham, D. J., Staffa, J. A., Kornegay, C. J., and Dal Pan, G. J., Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs, Pharmacoepidemiol Drug Saf, vol. 17, pp. 315-21, 2008.
A. A. Florio, Graubard, B. I., Yang, B., Thistle, J. E., Bradley, M. C., McGlynn, K. A., and Petrick, J. L., Oophorectomy and risk of non-alcoholic fatty liver disease and primary liver cancer in the Clinical Practice Research Datalink, Eur J Epidemiol, 2019.
S. A. Julious, Horspool, M. J., Davis, S., Franklin, M., Smithson, W. H., Norman, P., Simpson, R. M., Elphick, H., Bortolami, O., and Cooper, C., Open-label, cluster randomised controlled trial and economic evaluation of a brief letter from a GP on unscheduled medical contacts associated with the start of the school year: the PLEASANT trial, BMJ Open, vol. 8, p. e017367, 2018.
I. J. Higginson and Gao, W., Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United Kingdom cohort study, J Clin Oncol, vol. 30, pp. 4373-9, 2012.
L. Li, Setoguchi, S., Cabral, H., and Jick, S., Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database, Am J Epidemiol, vol. 178, pp. 559-69, 2013.
L. Li, Setoguchi, S., Cabral, H., and Jick, S., Opioid use for noncancer pain and risk of myocardial infarction amongst adults, J Intern Med, vol. 273, pp. 511-26, 2013.
L. Li, Setoguchi, S., Cabral, H., and Jick, S., Opioids and risk of type 2 diabetes in adults with non-cancer pain, Pain Physician, vol. 16, pp. 77-88, 2013.
P. Datta-Nemdharry, Thomson, A., and Beynon, J., Opportunities and Challenges in Developing a Cohort of Patients with Type 2 Diabetes Mellitus Using Electronic Primary Care Data, PLoS One, vol. 11, p. e0162236, 2016.
T. P. van Staa, Dyson, L., McCann, G., Padmanabhan, S., Belatri, R., Goldacre, B., Cassell, J., Pirmohamed, M., Torgerson, D., Ronaldson, S., Adamson, J., Taweel, A., Delaney, B., Mahmood, S., Baracaia, S., Round, T., Fox, R., Hunter, T., Gulliford, M., and Smeeth, L., The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials, Health Technol Assess, vol. 18, pp. 1-146, 2014.
R. C. Jones, Price, D., Ryan, D., Sims, E. J., von Ziegenweidt, J., Mascarenhas, L., Burden, A., Halpin, D. M., Winter, R., Hill, S., Kearney, M., Holton, K., Moger, A., Freeman, D., Chisholm, A., and Bateman, E. D., Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort, Lancet Respir Med, vol. 2, pp. 267-76, 2014.
P. Rockenschaub, Jhass, A., Freemantle, N., Aryee, A., Rafiq, M., Hayward, A., and Shallcross, L., Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD), J Antimicrob Chemother, 2019.
R. Perera, McFadden, E., McLellan, J., Lung, T., Clarke, P., Perez, T., Fanshawe, T., Dalton, A., Farmer, A., Glasziou, P., Takahashi, O., Stevens, J., Irwig, L., Hirst, J., Stevens, S., Leslie, A., Ohde, S., Deshpande, G., Urayama, K., Shine, B., and Stevens, R., Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling, Health Technol Assess, vol. 19, pp. 1-401, vii-viii, 2015.
K. Wing, Bhaskaran, K., Smeeth, L., van Staa, T. P., Klungel, O. H., Reynolds, R. F., and Douglas, I., Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury, BMJ Open, vol. 6, p. e012102, 2016.
A. Nicholson, Ford, E., Davies, K. A., Smith, H. E., Rait, G., Tate, A. R., Petersen, I., and Cassell, J., Optimising use of electronic health records to describe the presentation of rheumatoid arthritis in primary care: a strategy for developing code lists, PLoS One, vol. 8, p. e54878, 2013.
J. Spoendlin, Meier, C., Jick, S. S., and Meier, C. R., Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study, Ann Med, vol. 47, pp. 492-8, 2015.
J. Zhang, Haines, C., Watson, A. J. M., Hart, A. R., Platt, M. J., Pardoll, D. M., Cosgrove, S. E., Gebo, K. A., and Sears, C. L., Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study, Gut, 2019.
C. Garriga, Pazianas, M., Hawley, S., Delmestri, A., Prieto-Alhambra, D., Cooper, C., and Judge, A., Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study, Ann N Y Acad Sci, vol. 1415, pp. 34-46, 2018.
D. Alarkawi, Ali, M. S., Bliuc, D., Pallares, N., Tebe, C., Elhussein, L., Caskey, F. J., Arden, N. K., Ben-Shlomo, Y., Abrahamsen, B., Diez-Perez, A., Pascual, J., Perez-Saez, M. J., Center, J. R., Judge, A., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., Oral bisphosphonate use and all-cause mortality in patients with moderate-severe (grade 3B-5D) chronic kidney disease: a population-based cohort study, J Bone Miner Res, 2020.
A. Grosso, Douglas, I., Hingorani, A., MacAllister, R., and Smeeth, L., Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis, PLoS One, vol. 4, p. e4720, 2009.
J. Green, Czanner, G., Reeves, G., Watson, J., Wise, L., and Beral, V., Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort, Bmj, vol. 341, p. c4444, 2010.
J. Erviti, Alonso, A., Oliva, B., Gorricho, J., Lopez, A., Timoner, J., Huerta, C., Gil, M., and de Abajo, F., Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study, BMJ Open, vol. 3, 2013.
J. Erviti, Alonso, A., Gorricho, J., and Lopez, A., Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case-control study, BMJ Open, vol. 3, 2013.
R. D. Farmer, Lawrenson, R. A., Todd, J. C., Williams, T. J., and MacRae, K., Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database, Hum Reprod Update, vol. 5, pp. 688-706, 1999.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Zhang, B., and Cooper, C., Oral corticosteroids and fracture risk: relationship to daily and cumulative doses, Rheumatology (Oxford), vol. 39, pp. 1383-9, 2000.
[Page last reviewed 5 August 2020]